Subscribe
shutterstock_2142775731_artemisdiana
ArtemisDiana / Shutterstock.com
12 June 2023FeaturesBiotechnologyLauris Kemp, Claire Irvine and Susan Keston

Bioinformatics: a guide to IP protection

Bioinformatics is a buzzword at the moment. The ability of modern computing systems to process complex biological data has meant healthcare and biotech is changing.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
COVID-19: Protection of IP for AI tools
1 September 2020   As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Asia
COVID-19: Protection of IP for AI tools
1 September 2020   As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.

More on this story

Asia
COVID-19: Protection of IP for AI tools
1 September 2020   As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.

More features

Sarepta wins $115M in patent dispute over muscular dystrophy drug
CREATES Act unfairly tips the scales to generics
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
‘A marathon and a sprint at the same time’: How we won $452m damages
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
Trump’s return sparks calls for pro-patent agenda
EOFlow ordered to pay rival $452m over insulin patch trade secrets